• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

HLA-E、HLA-F和HLA-G的四聚体复合物

Tetrameric complexes of HLA-E, HLA-F, and HLA-G.

作者信息

Allan David S J, Lepin Eric J M, Braud Veronique M, O'Callaghan Christopher A, McMichael Andrew J

机构信息

Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, OX3 9DS, UK.

出版信息

J Immunol Methods. 2002 Oct 1;268(1):43-50. doi: 10.1016/s0022-1759(02)00199-0.

DOI:10.1016/s0022-1759(02)00199-0
PMID:12213342
Abstract

HLA-E, HLA-F, and HLA-G are human nonclassical MHC class Ib molecules. To study the function and identify potential ligands of these molecules, we constructed tetrameric complexes. In this brief review, we discuss the methods used to produce such tetramers and the interesting results they provided. HLA-E tetramers bound to natural killer (NK) cells and T cells, allowing the identification of CD94/NKG2 molecules as receptors for HLA-E. HLA-G tetramers interacted with immunoglobulin-like transcript-2 (ILT2) and ILT4 receptors, aiding the understanding of HLA-G function during pregnancy. Tetrameric complexes of HLA-F also bound to ILT2 and ILT4.

摘要

HLA - E、HLA - F和HLA - G是人类非经典的MHC Ib类分子。为了研究这些分子的功能并鉴定其潜在配体,我们构建了四聚体复合物。在这篇简短的综述中,我们讨论了用于产生此类四聚体的方法以及它们所提供的有趣结果。HLA - E四聚体与自然杀伤(NK)细胞和T细胞结合,从而能够鉴定出CD94/NKG2分子作为HLA - E的受体。HLA - G四聚体与免疫球蛋白样转录物2(ILT2)和ILT4受体相互作用,有助于理解妊娠期间HLA - G的功能。HLA - F的四聚体复合物也与ILT2和ILT4结合。

相似文献

1
Tetrameric complexes of HLA-E, HLA-F, and HLA-G.HLA-E、HLA-F和HLA-G的四聚体复合物
J Immunol Methods. 2002 Oct 1;268(1):43-50. doi: 10.1016/s0022-1759(02)00199-0.
2
Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G.人类抑制性受体免疫球蛋白样转录物2(ILT2)和ILT4与CD8竞争结合MHC I类分子,并优先结合HLA - G。
Proc Natl Acad Sci U S A. 2003 Jul 22;100(15):8856-61. doi: 10.1073/pnas.1431057100. Epub 2003 Jul 9.
3
Tetrameric complexes of human histocompatibility leukocyte antigen (HLA)-G bind to peripheral blood myelomonocytic cells.人类组织相容性白细胞抗原(HLA)-G的四聚体复合物与外周血髓单核细胞结合。
J Exp Med. 1999 Apr 5;189(7):1149-56. doi: 10.1084/jem.189.7.1149.
4
The ILT2(LIR1) and CD94/NKG2A NK cell receptors respectively recognize HLA-G1 and HLA-E molecules co-expressed on target cells.ILT2(LIR1)和CD94/NKG2A自然杀伤细胞受体分别识别在靶细胞上共表达的HLA-G1和HLA-E分子。
Eur J Immunol. 1999 Jan;29(1):277-83. doi: 10.1002/(SICI)1521-4141(199901)29:01<277::AID-IMMU277>3.0.CO;2-4.
5
Functional characterization of HLA-F and binding of HLA-F tetramers to ILT2 and ILT4 receptors.HLA-F的功能特性以及HLA-F四聚体与ILT2和ILT4受体的结合
Eur J Immunol. 2000 Dec;30(12):3552-61. doi: 10.1002/1521-4141(200012)30:12<3552::AID-IMMU3552>3.0.CO;2-L.
6
Kinetics and peptide dependency of the binding of the inhibitory NK receptor CD94/NKG2-A and the activating receptor CD94/NKG2-C to HLA-E.抑制性自然杀伤细胞受体CD94/NKG2 - A和激活受体CD94/NKG2 - C与HLA - E结合的动力学及肽依赖性
EMBO J. 1999 Aug 2;18(15):4250-60. doi: 10.1093/emboj/18.15.4250.
7
Analysis of HLA-E peptide-binding specificity and contact residues in bound peptide required for recognition by CD94/NKG2.HLA-E肽结合特异性及CD94/NKG2识别所需结合肽中接触残基的分析。
J Immunol. 2003 Aug 1;171(3):1369-75. doi: 10.4049/jimmunol.171.3.1369.
8
HLA-E is expressed on trophoblast and interacts with CD94/NKG2 receptors on decidual NK cells.HLA-E在滋养层细胞上表达,并与蜕膜自然杀伤细胞上的CD94/NKG2受体相互作用。
Eur J Immunol. 2000 Jun;30(6):1623-31. doi: 10.1002/1521-4141(200006)30:6<1623::AID-IMMU1623>3.0.CO;2-M.
9
HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C.人类白细胞抗原E(HLA-E)与自然杀伤细胞受体CD94/NKG2A、B及C相结合。
Nature. 1998 Feb 19;391(6669):795-9. doi: 10.1038/35869.
10
HLA-G modulates immune responses by diverse receptor interactions.HLA-G通过多种受体相互作用调节免疫反应。
Semin Cancer Biol. 2003 Oct;13(5):317-23. doi: 10.1016/s1044-579x(03)00022-1.

引用本文的文献

1
The progression of multiple myeloma is regulated by LILRB1 via the GATA2-SAGE1 pathway.多发性骨髓瘤的进展由LILRB1通过GATA2-SAGE1途径调控。
Br J Haematol. 2025 Jul;207(1):69-79. doi: 10.1111/bjh.20144. Epub 2025 May 25.
2
Identification of copy number variants contributing to hallux valgus.导致拇外翻的拷贝数变异的鉴定。
Front Genet. 2023 Mar 23;14:1116284. doi: 10.3389/fgene.2023.1116284. eCollection 2023.
3
Evolution and molecular interactions of major histocompatibility complex (MHC)-G, -E and -F genes.主要组织相容性复合体 (MHC)-G、-E 和 -F 基因的进化和分子相互作用。
Cell Mol Life Sci. 2022 Aug 4;79(8):464. doi: 10.1007/s00018-022-04491-z.
4
Leukocyte immunoglobulin-like receptor subfamily B: therapeutic targets in cancer.白细胞免疫球蛋白样受体B亚家族:癌症中的治疗靶点
Antib Ther. 2021 Feb 9;4(1):16-33. doi: 10.1093/abt/tbab002. eCollection 2021 Jan.
5
Maternal HLA Ib Polymorphisms in Pregnancy Allo-Immunization.妊娠同种免疫中的母体 HLA Ib 多态性。
Front Immunol. 2021 Mar 30;12:657217. doi: 10.3389/fimmu.2021.657217. eCollection 2021.
6
: Transcriptional Activity and HLA-E Mobilization.转录活性和 HLA-E 动员。
Front Immunol. 2020 Jan 17;10:2986. doi: 10.3389/fimmu.2019.02986. eCollection 2019.
7
What the HLA-I!-Classical and Non-classical HLA Class I and Their Potential Roles in Type 1 Diabetes.什么是 HLA-I!经典和非经典 HLA I 类分子及其在 1 型糖尿病中的潜在作用。
Curr Diab Rep. 2019 Dec 9;19(12):159. doi: 10.1007/s11892-019-1245-z.
8
European Patent in Immunoncology: From Immunological Principles of Implantation to Cancer Treatment.欧洲免疫肿瘤学专利:从植入的免疫学原理到癌症治疗。
Int J Mol Sci. 2019 Apr 12;20(8):1830. doi: 10.3390/ijms20081830.
9
HLA class Ib in pregnancy and pregnancy-related disorders.妊娠及妊娠相关疾病中的HLA Ib类分子
Immunogenetics. 2017 Aug;69(8-9):581-595. doi: 10.1007/s00251-017-0988-4. Epub 2017 Jul 11.
10
Association of HLA-A and Non-Classical HLA Class I Alleles.HLA-A 和非经典 HLA I 类等位基因的关联。
PLoS One. 2016 Oct 4;11(10):e0163570. doi: 10.1371/journal.pone.0163570. eCollection 2016.